MIRA INFORM REPORT

 

 

Report Date :

14.12.2012

 

IDENTIFICATION DETAILS

 

Name :

MYLAN PHARMACEUTICALS PRIVATE LIMITED (w. e. f. 08.08.2011)

 

 

Formerly Known As :

MYLAN INDIA PRIVATE LIMITED

 

 

Registered Office :

One India Bulls Centre, Tower 2-B, 7th Floor, 841, Senapati Bapat Marg, Elphinstone Road (West), Mumbai – 400013, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

03.03.1997

 

 

Com. Reg. No.:

11.106287

 

 

Capital Investment / Paid-up Capital :

Rs. 199.050 Millions

 

 

CIN No.:

[Company Identification No.]

U73100MH1997PTC106267

 

 

PAN No.:

[Permanent Account No.]

AABCM9323J

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

To carry on the business of research and development of products, processes and systems, investigation and experiment on drugs, pharmaceuticals and chemicals of any nature and kind whatsoever for and on behalf of Group Companies, production of bulk pharmaceuticals and chemicals, trading in pharmaceutical products, provide consultancy services and manufacture on loan licensing.

 

 

No. of Employees :

Information Denied By Management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (34)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 1000000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established of ‘Mylan Group B. V., Netherlands. It is an established company having moderate track.

 

The Latest financials are not made available. The management has also denied to disclose any details of the subject to us.

 

As per previous year’s record, the company has incurred loss from its operations.

 

However, trade relations are reported as fair. Business is active. Payments terms are unknown in absence of latest financials.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

INDIAN ECONOMIC OVERVIEW

 

India is developing into an open-market economy, yet traces of its past autarkic policies remain. Economic liberalization, including industrial deregulation, privatization of state-owned enterprises, and reduced controls on foreign trade and investment, began in the early 1990s and has served to accelerate the country's growth, which has averaged more than 7% per year since 1997. India's diverse economy encompasses traditional village farming, modern agriculture, handicrafts, a wide range of modern industries, and a multitude of services. Slightly more than half of the work force is in agriculture, but services are the major source of economic growth, accounting for more than half of India's output, with only one-third of its labor force. India has capitalized on its large educated English-speaking population to become a major exporter of information technology services and software workers. In 2010, the Indian economy rebounded robustly from the global financial crisis - in large part because of strong domestic demand - and growth exceeded 8% year-on-year in real terms. However, India's economic growth in 2011 slowed because of persistently high inflation and interest rates and little progress on economic reforms. High international crude prices have exacerbated the government's fuel subsidy expenditures contributing to a higher fiscal deficit, and a worsening current account deficit. Little economic reform took place in 2011 largely due to corruption scandals that have slowed legislative work. India's medium-term growth outlook is positive due to a young population and corresponding low dependency ratio, healthy savings and investment rates, and increasing integration into the global economy. India has many long-term challenges that it has not yet fully addressed, including widespread poverty, inadequate physical and social infrastructure, limited non-agricultural employment opportunities, scarce access to quality basic and higher education, and accommodating rural-to-urban migration.

Source : CIA

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

STANDARD AND POOR

Rating

BBB : LONG TERM CREDIT RATINGS

Rating Explanation

Adequate protection parameters. However, adverse economic conditions or charging circumstances are more likely to lead to a weakened capacity of the obligor to meet its financial commitment on the obligation.

Date

November 20, 2012

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION DENIED BY

 

Name :

Mr. Jignesh Dave

Designation :

Account Department

Contact No.:

91-22-33021000 

Date :

12.12.2012

 

 

LOCATIONS

 

Registered Office :

One India Bulls Centre, Tower 2-B, 7th Floor, 841, Senapati Bapat Marg, Elphinstone Road (West), Mumbai – 400013, Maharashtra, India

Tel. No.:

91-22-33021000

Fax No.:

91-22-32021090

E-Mail :

jyoti@mylanindia.com

joyti@mylan.in

stame@mylan.in

ashwini.kandlikar@mylan.in

Website :

http://www.mylon.in 

 

 

DIRECTORS

 

As on: 30.09.2011

 

Name :

Mr. Abhay Sudhir Gaitonde

Designation :

Director

Address :

B 1102, Vikas Palms, Dr. Ambedkar Road, Charai, Thane (West), Mumbai – 400602, Maharashtra, India

Date of Birth/Age :

27.10.1966

Date of Appointment :

01.02.2008

DIN No.:

02058773

 

 

Name :

Mr. Ramamoorthy Jayakumar

Designation :

Director

Address :

101, Creative Palace, 10-2-88, R. No. 3, SR. No. 7, W. Marredpally, Secunderabad, Andhra Pradesh, India

Date of Birth/Age :

09.04.1971

Qualification :

B. Sc

Experience :

18 Years

Date of Appointment :

07.10.2009

DIN No.:

02819800

 

 

Name :

Mr. Anirudh Raghavender Deshpande

Designation :

Director

Address :

2-1-415/A, St No. 4 Nallakuna, Hyderabad – 500044, Andhra Pradesh, India 

Date of Birth/Age :

14.04.1963

Date of Appointment :

28.09.2012

DIN No.:

03256804

 

 

Name :

Mr. Preetish Mohan Toraskar

Designation :

Whole-time director

Address :

B-6, Greenland, Plot No. 32, Sector 16-A, Vashi, Navi Mumbai – 400703, Maharashtra, India 

Date of Birth/Age :

11.09.1970

Date of Appointment :

28.09.2012

DIN No.:

05299763

 

 

Name :

Mr. Gopalji Mehrotra

Designation :

Director

Address :

26, Hill Ridge Villas ISB Road, Gachibowli , Hyderabad – 500032, Andhra Pradesh, India 

Date of Birth/Age :

28.01.1967

Date of Appointment :

28.09.2012

DIN No.:

05302378

 

 

KEY EXECUTIVES

 

Name :

Mr. Ashwini Khandlikar

Designation :

Secretary

Address :

House No. 3-4-512/58 Barkatpura, Himayatnagar, Hyderabad – 500027, Andhra Pradesh, India

Date of Birth/Age :

01.02.1980

Date of Appointment :

16.09.2011

PAN No.:

AQAPK5399L

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 30.09.2011

 

Names of Shareholders

 

No. of Shares

Mylan Group B. V, Netherlands

 

9999998

Mylan B.V , Netherlands

 

2

Total

 

10000000

 

Equity Share Break up (Percentage of Total Equity)

 

As on: 30.09.2011

 

Category

 

Percentage

 

 

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

 

100.00

 

 

 

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

To carry on the business of research and development of products, processes and systems, investigation and experiment on drugs, pharmaceuticals and chemicals of any nature and kind whatsoever for and on behalf of Group Companies, production of bulk pharmaceuticals and chemicals, trading in pharmaceutical products, provide consultancy services and manufacture on loan licensing.

 

 

Products :

 

Product Description

Salmeterol Xinafoate

Pramipexole

Business support services

 

 

PRODUCTION STATUS As on 31.03.2011

 

Particulars

Unit

Licensed Capacity

Installed Capacity

Actual Production

Active Pharmaceuticals Ingredients

Kg

 

504-6240

123.76

 

Note :

  • Licensed capacity is not applicable in terms of the Government of India Notification No. 477(E) dated 25thJuly 1991.
  • The licensed and installed capacities are as certified by management.
  • Includes captive consumption

 

GENERAL INFORMATION

 

No. of Employees :

Information Denied By Management

 

 

Bankers :

Not Available

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Deloitte Haskins and Sells

Chartered Accountants

Address :

Mumbai, Maharashtra, India

PAN No.:

AACFD3771D

 

 

Related Parties :

Mylan Laboratories India Limited, India

CIN No.: U24231AP1984PLC005146

 

 

Fellow Subsidiaries :

  • Gerard Laboratories, Ireland
  • Dey L. P., U.S.A.
  • Mylan Pharmaceuticals Inc., U.S.A.
  • Mylan Laboratories India Private Limted, India

CIN No.: U74140DL2007PTC157347

  • Matrix Laboratories Inc., U.S.A.
  • Matrix Laboratories Limited, India

 

 

Ultimate Holding Company :

Mylan Inc., U.S.A.

 

 

Holding Company :

Mylan Group B. V., Netherlands

 

 

CAPITAL STRUCTURE

 

As on: 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000000

Equity Shares

Rs.10/- each

Rs. 100.000 Millions

10000000

Preferences Shares

Rs. 10/- each

Rs. 100.000  Millions

 

Total

 

Rs. 200.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000000

Equity Shares

Rs.10/- each

Rs. 100.000 Millions

9904986

Preferences Shares

Rs.10/- each

Rs. 99.050 Millions

 

Total

 

Rs. 199.050 Millions

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

199.050

199.050

199.050

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

189.157

322.042

322.042

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

388.207

521.092

521.092

LOAN FUNDS

 

 

 

1] Secured Loans

0.000

0.000

0.000

2] Unsecured Loans

0.000

0.000

0.000

TOTAL BORROWING

0.000

0.000

0.000

DEFERRED TAX LIABILITIES

0.000

42.696

42.696

 

 

 

 

TOTAL

388.207

563.788

563.788

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

5.567

373.506

373.506

Capital work-in-progress

214.742

7.985

7.985

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

4.939

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

0.000

88.456

88.456

 

Sundry Debtors

135.426

136.894

136.894

 

Cash & Bank Balances

151.405

33.724

33.724

 

Other Current Assets

8.276

0.753

0.000

 

Loans & Advances

39.453

48.527

49.280

Total Current Assets

334.560

308.354

308.354

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

93.605

65.352

67.571

 

Other Current Liabilities

57.155

6.458

4.239

 

Provisions

20.841

54.247

54.247

Total Current Liabilities

171.601

126.057

126.057

Net Current Assets

162.959

182.297

182.297

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

388.207

563.788

563.788

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

484.805

548.723

548.723

 

 

Other Income

7.943

11.035

11.035

 

 

TOTAL                                    

492.748

559.758

559.758

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

682.826

347.734

347.734

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION                                  

(190.078)

212.024

212.024

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

12.515

25.359

25.359

 

 

 

 

 

 

PROFIT BEFORE TAX

(177.563)

186.665

186.665

 

 

 

 

 

Less

TAX                                                                 

(44.678)

69.128

69.128

 

 

 

 

 

 

PROFIT AFTER TAX                

(132.885)

117.537

117.537

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

26.97

20.99

20.99

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

36.63

34.02

34.02

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

52.21

27.37

27.37

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.46

0.36

0.36

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.44

0.24

0.24

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.95

2.45

2.45

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Details of Sundry Creditors:

(Rs in Millions)

Particulars

31.03.2011

31.03.2012

31.03.2011

 

 

 

 

Creditors

93.605

65.352

67.571

Total

93.605

65.352

67.571

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

No

24]

Banking facility details

No

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

No

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

NOTE:

 

The registered office of the company has been shifted from Plot 1A/2, M.I.D.C. Industrial Estate Taloja, Panvel, District Raigad, Panvel – 410208, Maharashtra India to present address w.e.f. 30.06.2011

 

 

BACKGROUND

 

Mylan India Private Limited (‘the Company’) was incorporated on March 3, 1997 as a private limited company. The main objectives of the Company as amended on September 15, 2008 are to carry on the business of research and development of products, processes and systems, investigation and experiment on drugs, pharmaceuticals and chemicals of any nature and kind whatsoever for and on behalf of Group Companies, production of bulk pharmaceuticals and chemicals, trading in pharmaceutical products, provide consultancy services and manufacture on loan licensing. The object clause has been further amended to include purchase or otherwise acquire, maintain, sell and/or give on operating / finance lease all kinds of movable and /or immovable plant, machinery, equipment, medical equipment, office equipment or any other electronic and non electronic equipment relating to pharmaceutical and chemical industry.

 

Effective March 27, 2008 the name of the Company has been changed from Merck Development Centre Private Limited to Mylan Development Centre Private Limited. Effective September 15, 2008 the name of the Company was further changed from Mylan Development Centre Private Limited to Mylan India Private Limited. Effective August 08, 2011 the name of the Company has been changed from Mylan India Private Limited to Mylan Pharmaceuticals Private Limited. The amended Certificate of Incorporation was received from the Registrar of Companies.

 

During the year, Company has changed its statutory year from Calendar Year January to December to Financial Year April to March. As a result, the current statutory year is for a period from January 2010 to March 2011.

 

FIXED ASSETS

 

  • Land
  • Factory Building
  • Plant and Machinery
  • Furniture and Fixtures
  • Vehicles
  • Computer

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 54.23

UK Pound

1

Rs. 87.53

Euro

1

Rs. 70.94

 

 

INFORMATION DETAILS

 

Information Gathered by :

PDT

 

 

Report Prepared by :

VRN

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

2

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

34

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.